Clinical trial
A Prospective Phase II Clinical Study of Carbon Ion Re-irradiation in Unresectable Locally Recurrent Rectal Cancer
NCT05807984 is registered in ClinicalTrials.gov with Xin Cai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Phase II Clinical Study of Carbon Ion Re-irradiation in Unresectable Locally Recurrent Rectal Cancer
- Lead sponsor
- Xin Cai
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- May 1, 2023
- Completion date
- December 31, 2026
- Enrollment
- 31 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer, recurrent